NYSE: CWANClearwater Analytics Holdings Inc Stock
$22.05-0.01 (-0.05%)
Updated Jul 15, 2025
CWAN Price
$22.05
Fair Value Price
N/A
Market Cap
$6.25B
52 Week Low
$19.18
52 Week High
$35.71
P/E
11.25x
P/B
5.6x
P/S
13.36x
PEG
N/A
Dividend Yield
N/A
Revenue
$475.95M
Earnings
$428.99M
Gross Margin
73%
Operating Margin
-5.67%
Profit Margin
90.1%
Debt to Equity
0.13
Operating Cash Flow
$89M
Beta
0.95
Next Earnings
Jul 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CWAN Overview
Clearwater Analytics Holding Inc is a software-as-a-service fintech company that provides automated investment accounting, performance, compliance, and risk reporting for insurance companies, asset managers, corporations, banks, governments, and other institutions. Notable clients include Mutual of Omaha, Arch Capital Group, Wilton Re., J.P. Morgan Asset Management, Facebook, Cisco, and Oracle. Clearwater was founded in 2004 and is headquartered in Boise, ID.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CWAN's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: App
Industry Rating
B
CWAN
Ranked#88 of 203
Ranked#88 of 203
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $28.18 | A | |
| $49.98 | A | |
| $45.49 | A |
Be the first to know about important CWAN news, forecast changes, insider trades & much more!
CWAN News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CWAN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CWAN is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CWAN is good value based on its earnings relative to its share price (11.25x), compared to the US market average (31.02x)
P/E vs Market Valuation
CWAN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CWAN due diligence checks available for Premium users.
Valuation
CWAN price to earnings (PE)
For valuing profitable companies with steady earnings
Company
11.25x
Industry
46.26x
Market
31.02x
CWAN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CWAN is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CWAN price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.6x
Industry
7x
CWAN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CWAN's financial health
Profit margin
Revenue
$126.9M
Net Income
$6.5M
Profit Margin
5.1%
CWAN's Earnings (EBIT) of -$27.01M... subscribe to Premium to read more.
Interest Coverage Financials
CWAN's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.3B
Liabilities
$142.7M
Debt to equity
0.13
CWAN's short-term assets ($422.06M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CWAN's short-term assets ($422.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CWAN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$24.5M
Investing
$99.5M
Financing
-$27.2M
CWAN's operating cash flow ($88.78M)... subscribe to Premium to read more.
Debt Coverage Financials
CWAN vs App Stocks
Clearwater Analytics Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.